Clinical trial

DHEA Bioavailability Following Administration of Vaginal Suppositories in…

NCT00429806 · CHU de Quebec-Universite Laval, Other · Completed

Key facts

NCT number NCT00429806
Title DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy
Official title DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy-Phase I Randomized,Placebo-Controlled, Double-Blind Study.
Lead sponsor CHU de Quebec-Universite Laval, Other
Status Completed
Phase Phase 1
Study type Interventional
Conditions Vaginal Atrophy
Intervention type Drug
Interventions DHEA, Placebo
Enrollment 40
Start date Nov 1, 2006
Primary completion Mar 1, 2007
Completion Jul 1, 2007
First posted Feb 1, 2007
Last update posted Apr 7, 2017
Countries Canada

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies